Literature DB >> 25483646

Factors associated with pneumococcal vaccination among an urban elderly population in China.

Shijun Liu1, Erping Xu, Yan Liu, Yuyang Xu, Jun Wang, Jian Du, Xiaoping Zhang, Xinren Che, Wenwen Gu.   

Abstract

OBJECTIVES: To investigate the coverage of the 23-valent pneumococcal polysaccharide vaccine (23-PPV) in the Chinese urban elderly population and to understand the attitudes, knowledge and beliefs of this population toward the 23-PPV vaccination.
METHODS: A cross-sectional approach was employed to survey the willingness of this population to receive the 23-PPV vaccination. Two thousand 9 hundred 2 six subjects over the age of 60 y were enrolled via a multi-stage random sampling method from the urban community population in Hangzhou, China. The relationships between the variables and the willingness to receive the 23-PPV vaccination were computed as odds ratios (ORs) by multivariate analysis.
RESULTS: Of the participants, 21.77% were willing to undergo 23-PPV vaccination, and 61.65% of the subjects agreed that pneumonia is a serious disease among elderly people. The rate of reasonable perceptions about vaccination, including the perception about vaccine efficacy and safety, among the subjects was below 50%. Only 1.23% of subjects had been vaccinated with 23-PPV, and a similarly low rate was observed for the seasonal influenza vaccine (4.17%). The factors that were independently related to the willingness to receive the 23-PPV vaccine included consensus with the hazards of pneumonia (OR = 1.67, 95% CI: 1.28 - 2.17), the safety of vaccination (OR = 2.00, 95% CI: 1.54 - 2.59), advice about the 23-PPV vaccination from family members (OR = 2.37, 95% CI: 1.39 - 4.40), influenza vaccination history (OR = 2.57, 95% CI: 1.66 - 3.98) and pneumococcal vaccination history (OR = 7.48, 95% CI: 2.4-22.92).
CONCLUSION: The administration of the 23-PPV vaccine among the urban elderly population is not optimistic in China. Emphasis on persuasion from families and the improvement of knowledge about vaccination might encourage elderly people to get the 23-PPV vaccination. Suggestions from physicians did not affect the participants' willingness to get the 23-PPV vaccination in multivariate analysis, but elderly people typically visited the Community Health Center (CHC) in their residential districts, and thus, systematic encouragement from healthcare physicians might be the key to increasing 23-PPV vaccination.

Entities:  

Keywords:  23-PPV, 23-valent pneumococcal polysaccharide vaccine; 23-valent pneumococcal polysaccharide vaccine; CHC, community health center; CI, confidence interval; HR, health record; IPD, invasive pneumococcal disease; OR, odds ratios; cross-sectional study; elderly population; immunization; pneumococcal vaccination

Mesh:

Substances:

Year:  2014        PMID: 25483646      PMCID: PMC5443071          DOI: 10.4161/21645515.2014.972155

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  23 in total

Review 1.  Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.

Authors:  David S Fedson; Laurence Nicolas-Spony; Peter Klemets; Mark van der Linden; Agostinho Marques; Luis Salleras; Sandrine I Samson
Journal:  Expert Rev Vaccines       Date:  2011-08-03       Impact factor: 5.217

2.  [Technical guideline on application of pneumococcal vaccine in China (2012)].

Authors:  Ying Qin; Hong-jie Yu
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2012-11

3.  Adult pneumococcal vaccination: a review of physician and patient barriers.

Authors:  Tammy A Mieczkowski; Stephen A Wilson
Journal:  Vaccine       Date:  2002-01-31       Impact factor: 3.641

4.  Understanding the reasons for the underuse of pneumococcal vaccination by community-dwelling older African Americans.

Authors:  Linda G Jones; Yan Zhang; Mustafa I Ahmed; O James Ekundayo; Shamima Akhter; Patricia Sawyer; Inmaculada Aban; Richard V Sims; Ali Ahmed
Journal:  J Am Geriatr Soc       Date:  2010-12       Impact factor: 5.562

5.  Importance of patients' perceptions and general practitioners' recommendations in understanding missed opportunities for immunisations in Swiss adults.

Authors:  P A Bovier; E Chamot; M Bouvier Gallacchi; L Loutan
Journal:  Vaccine       Date:  2001-09-14       Impact factor: 3.641

Review 6.  Strategies for the control of pneumococcal diseases.

Authors:  K Mulholland
Journal:  Vaccine       Date:  1999-07-30       Impact factor: 3.641

7.  Physician attitudes and beliefs associated with patient pneumococcal polysaccharide vaccination status.

Authors:  Tammy A Santibanez; Richard Kent Zimmerman; Mary Patricia Nowalk; Ilene Katz Jewell; Inis J Bardella
Journal:  Ann Fam Med       Date:  2004 Jan-Feb       Impact factor: 5.166

8.  Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.

Authors:  Angela Domínguez; Jesús Castilla; Pere Godoy; Miguel Delgado-Rodríguez; Marc Saez; Núria Soldevila; Jenaro Astray; José María Mayoral; Vicente Martín; José María Quintana; Fernando González-Candelas; Juan Carlos Galán; Sonia Tamames; Ady Castro; Maretva Baricot; Olatz Garín; Tomas Pumarola
Journal:  Hum Vaccin Immunother       Date:  2013-04-01       Impact factor: 3.452

9.  Seasonal influenza vaccination coverage rate of target groups in selected cities and provinces in China by season (2009/10 to 2011/12).

Authors:  Lei Zhou; Qiru Su; Zhen Xu; Ao Feng; Hui Jin; Shiyuan Wang; Zijian Feng
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

10.  Cross-sectional study on attitudes among general practitioners towards pneumococcal vaccination for middle-aged and elderly population in Hong Kong.

Authors:  Lancelot W H Mui; Alvin Y S Chan; Albert Lee; John Lee
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

View more
  10 in total

1.  Facilitators and barriers to completing recommended doses of pneumococcal vaccination among community-living individuals aged ≥65 years in Hong Kong - a population-based study.

Authors:  Zixin Wang; Yuan Fang; Margaret Ip; Mason Lau; Joseph T F Lau
Journal:  Hum Vaccin Immunother       Date:  2020-07-02       Impact factor: 3.452

2.  Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study.

Authors:  Angela Domínguez; Núria Soldevila; Diana Toledo; Pere Godoy; Núria Torner; Luis Force; Jesús Castilla; José María Mayoral; Sonia Tamames; Vicente Martín; Mikel Egurrola; Francisco Sanz; Jenaro Astray
Journal:  Hum Vaccin Immunother       Date:  2016-04-11       Impact factor: 3.452

3.  Knowledge, attitude, and practice regarding infection and vaccination in patients with rheumatic diseases in China.

Authors:  Yutong Jiang; Xi Zhang; Qing Lv; Jun Qi; Xinghua Guo; Qiujing Wei; Zetao Liao; Zhiming Lin; Jieruo Gu
Journal:  Hum Vaccin Immunother       Date:  2019-03-19       Impact factor: 3.452

4.  Vaccination pattern of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Hangzhou, China: a coverage and adverse events following immunization of different age groups.

Authors:  Yan Liu; Yuyang Xu; Jun Wang; Xinren Che; Wenwen Gu; Jian Du; Xiaoping Zhang; Xuechao Zhang; Wei Jiang; Junfang Chen; Zhijie An
Journal:  Hum Vaccin Immunother       Date:  2020-06-12       Impact factor: 3.452

5.  Illness representations on pneumonia and pneumococcal vaccination uptake among community-living Chinese people with high-risk conditions aged ≥65 years --- a population-based study.

Authors:  Zixin Wang; Yuan Fang; Willa Dong; Mason Lau; Phoenix K H Mo
Journal:  Hum Vaccin Immunother       Date:  2020-09-29       Impact factor: 3.452

6.  Factors associated with pneumococcal vaccination in elderly people: a cross-sectional study among elderly club members in Miyakonojo City, Japan.

Authors:  Akihiro Sakamoto; Charnchudhi Chanyasanha; Dusit Sujirarat; Nobuhiro Matsumoto; Masamitsu Nakazato
Journal:  BMC Public Health       Date:  2018-10-12       Impact factor: 3.295

7.  Correlation between family physician's direct advice and pneumococcal vaccination intention and behavior among the elderly in Japan: a cross-sectional study.

Authors:  Mariko Higuchi; Keiichiro Narumoto; Takahiro Goto; Machiko Inoue
Journal:  BMC Fam Pract       Date:  2018-09-05       Impact factor: 2.497

8.  A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) revaccination coverage rate among elderly adults aged 65 and older and physician's attitude.

Authors:  Atsushi Nakamura; Kenji Kawakami; Akira Wakana; Temitope A Folaranmi; Tomoharu Iino
Journal:  Hum Vaccin Immunother       Date:  2020-02-11       Impact factor: 3.452

9.  Heightened Willingness toward Pneumococcal Vaccination in the Elderly Population in Shenzhen, China: A Cross-Sectional Study during the COVID-19 Pandemic.

Authors:  Minyi Zhang; Hongbiao Chen; Fei Wu; Qiushuang Li; Qihui Lin; He Cao; Xiaofeng Zhou; Zihao Gu; Qing Chen
Journal:  Vaccines (Basel)       Date:  2021-03-03

10.  The Current Status of Vaccine Uptake and the Impact of COVID-19 on Intention to Vaccination in Patients with COPD in Beijing.

Authors:  Zhu Song; Xiaofang Liu; Pingchao Xiang; Yingxiang Lin; Li Dai; Yanfei Guo; Jiping Liao; Yahong Chen; Ying Liang; Yongchang Sun
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-12-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.